VEGFA and COVID-19: Taken together, our study defines the molecular mechanism of VEGF overproduction in SARS‐CoV‐2 spike‐stimulated intestine and identifies ERK/VEGF as potential biomarkers and therapeutic targets of the intestinal inflammation and disease progression of COVID‐19.